Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
This study has been completed.
Sponsor:
Raptor Therapeutics Inc.
Information provided by (Responsible Party):
Raptor Therapeutics Inc.
ClinicalTrials.gov Identifier:
NCT01000961
First received: October 22, 2009
Last updated: September 17, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2011 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |